
Citizens (CIA) Stock Forecast & Price Target
Citizens (CIA) Analyst Ratings
Bulls say
Citizens is supported by a fundamentally attractive insurance franchise with a majority of revenue from life insurance and a footprint across 32 U.S. states and more than 70 countries, giving it diversified access to domestic and international policyholders. Its outlook is strengthened by stable operations in Domestic and International Insurance, while the broad geographic mix across the United States, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and other markets helps cushion localized weakness and supports long-term premium growth. With a strong balance sheet and continued demand for life coverage, the company appears well positioned to sustain earnings resilience and compound value over time.
Bears say
Citizens is viewed negatively because the recent run rate has forced lower production assumptions, higher cost estimates, and meaningful cuts to intrinsic value metrics, with revised 8% NAVPS falling to C$3.60 from a prior C$3.82 and earlier NAVPS estimates also reduced sharply. The outlook is further pressured by a challenging market backdrop where iron ore supply is expected to move from a ~25 Mt deficit in 2026E to a ~27 Mt surplus in 2027E and ~79 Mt in 2028E, while the P65 index averaged US$112.8/dmt in Q2 and is expected to drift lower. Execution risk remains elevated because the business is concentrated in a single asset, output has been hurt by DRPF commissioning inefficiencies, freight and diesel costs are outside management’s control, and the company lacks its own railway to port, which has pressured sales volumes.
This aggregate rating is based on analysts' research of Citizens and is not a guaranteed prediction by Public.com or investment advice.
Citizens (CIA) Analyst Forecast & Price Prediction
Start investing in Citizens (CIA)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Citizens (CIA) Forecast
Citizens (CIA) Analyst Forecast & Price Prediction
Start investing in Citizens (CIA)
Order type
Buy in
Order amount
Est. shares
0 shares